0
Articles |

Premalignant Evolution of Lung Cancer*: Gilles F. Filley Lecture

Wilbur A. Franklin, MD
Author and Funding Information

*From the University of Colorado Health Sciences Center, Denver, CO.

Correspondence to: Wilbur A. Franklin, MD, University of Colorado Health Sciences Center, 4200 E 9th Ave, Box B216, Denver, CO 80262; e-mail: wilbur.franklin@uchsc.edu



Chest. 2004;125(5_suppl):90S-94S. doi:10.1378/chest.125.5_suppl.90S
Text Size: A A A
Published online

Extract

Lung cancer continues to be the most lethal of human tumors and is expected to account for > 160,000 deaths in 2004.1 This high mortality has been attributed to the late stage of the disease at detection and to aggressive biological behavior. Because of this aggressive behavior, there is a relatively short window of opportunity in which to effectively treat the disease. However, if the preinvasive changes in progenitor cells that lead to carcinoma are recognized as part of the process of malignant transformation, then the window of opportunity for effective intervention is considerably widened. In such a paradigm, premalignancy is regarded as the disease, and carcinoma as the end point. The objective of this article is to review the evidence for the existence of premalignant lesions in the lower airways, to determine who develops the lesions and how to find them, and to describe the molecular and cellular properties of those lesions.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Vascular Endothelial Growth Factor Expression in Airways of Patients With Lung Cancer*: A Possible Diagnostic Tool of Responsive Angiogenic Status on the Host Side
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543